A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer (PolyDamas)
Last Updated August 24, 2024
Want to learn how to participate in this trial?
CR109323
OVERVIEW
-
Sexes Eligible for Study
all -
Age
years -
Phase
phase 11 -
Sites
Sites -
Status
Recruiting
SUMMARY
The purpose of this study is to identify the recommended Phase 2 (combination) dose (RP2CD) of the amivantamab and cetrelimab combination therapy in participants with non-small cell lung cancer (NSCLC) in Phase 1 (combination dose selection); and to evaluate the antitumor effect of the combination at the selected RP2CD in participants with NSCLC characterized on the basis of epidermal growth factor receptor (EGFR) and Programmed-cell death Ligand (PD-L)1 status, in the Phase 2 (expansion).
CONDITIONS
- Carcinoma, Non-Small-Cell Lung
ELIGIBILITY
Inclusion Criteria:
* Participant must have histologically or cytologically confirmed non-small cell lung cancer (NSCLC) (any histology), and must have metastatic NSCLC at the time of enrollment: Phase 1 (Combination Dose Selection) Cohort; Metastatic NSCLC progressed on or after st
DETAILS
LOCATIONS
Country (7) | City or Province (22) | Status |
United States | Los Alamitos Cancer and Blood Specialty Clinic |
RECRUITING
|
United States | Portland Providence Portland Medical Center |
RECRUITING
|
United States | Portland Providence Oncology and Hematology Care Clinic Westside |
RECRUITING
|
United States | Fairfax Virginia Cancer Specialists |
RECRUITING
|
Brazil | Sao Paulo Fundacao Antonio Prudente A C Camargo Cancer Center |
RECRUITING
|
South Korea | Seoul Seoul National University Hospital |
RECRUITING
|
South Korea | Seoul Severance Hospital Yonsei University Health System |
RECRUITING
|
South Korea | Seoul Samsung Medical Center |
RECRUITING
|
Malaysia | Kuala Lumpur University Malaya Medical Centre |
RECRUITING
|
Malaysia | Kuching Hospital Umum Sarawak |
RECRUITING
|
Türkiye | Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital |
RECRUITING
|
United States | Duarte City of Hope |
RECRUITING
|
United States | Irvine City of Hope Orange County Lennar Foundation Cancer Center |
RECRUITING
|
Brazil | Barretos Fundacao Pio XII |
RECRUITING
|
Brazil | Belo Horizonte Cetus Oncologia |
RECRUITING
|
Brazil | Curitiba CIONC Centro Integrado de Oncologia de Curitiba |
RECRUITING
|
Italy | Milano European Institute of Oncology |
RECRUITING
|
Italy | Verona Centro Ricerche Cliniche di Verona S r l |
RECRUITING
|
Poland | Lublin INSTYTUT GENETYKI I IMMUNOLOGII GENIM Sp z o o |
RECRUITING
|
Türkiye | Cankaya Ankara Bilkent City Hospital |
COMPLETED
|
Türkiye | Istanbul Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi |
RECRUITING
|
Türkiye | Sakarya Sakarya University Training and Research Hospital |
RECRUITING
|
33.80307, -118.07256
45.52345, -122.67621
45.52345, -122.67621
38.84622, -77.30637
-23.5475, -46.63611
37.566, 126.9784
37.566, 126.9784
37.566, 126.9784
3.1412, 101.68653
1.54999, 110.33333
39.91987, 32.85427
34.13945, -117.97729
33.66946, -117.82311
-20.55722, -48.56778
-19.92083, -43.93778
-25.42778, -49.27306
45.46427, 9.18951
45.4299, 10.98444
51.25, 22.56667
39.9179, 32.86268
41.01384, 28.94966
40.788855, 30.405954
Indicates 50+ sites in this region: click to zoom in.
Indicates 10+ sites in this region: click to zoom in.
Indicates < 10 sites in this region: click to zoom in.
Corresponds to individual site.